nodes	percent_of_prediction	percent_of_DWPC	metapath
Azacitidine—Glucosamine—TNF—psoriatic arthritis	0.0138	1	CrCbGaD
Azacitidine—DNMT3A—Amcinonide—Dexamethasone—psoriatic arthritis	0.00472	0.0798	CbGdCrCtD
Azacitidine—DNMT3A—Amcinonide—Betamethasone—psoriatic arthritis	0.00472	0.0798	CbGdCrCtD
Azacitidine—DNMT3A—Amcinonide—Triamcinolone—psoriatic arthritis	0.00461	0.078	CbGdCrCtD
Azacitidine—DNMT3A—Amcinonide—Prednisone—psoriatic arthritis	0.00437	0.074	CbGdCrCtD
Azacitidine—DNMT3A—Amcinonide—Prednisolone—psoriatic arthritis	0.00427	0.0723	CbGdCrCtD
Azacitidine—DNMT1—Budesonide—Methylprednisolone—psoriatic arthritis	0.00189	0.0321	CbGdCrCtD
Azacitidine—DNMT1—Budesonide—Betamethasone—psoriatic arthritis	0.00186	0.0316	CbGdCrCtD
Azacitidine—DNMT1—Budesonide—Dexamethasone—psoriatic arthritis	0.00186	0.0316	CbGdCrCtD
Azacitidine—DNMT1—Budesonide—Triamcinolone—psoriatic arthritis	0.00182	0.0308	CbGdCrCtD
Azacitidine—DNMT1—Budesonide—Prednisone—psoriatic arthritis	0.00173	0.0293	CbGdCrCtD
Azacitidine—DNMT1—Budesonide—Prednisolone—psoriatic arthritis	0.00169	0.0286	CbGdCrCtD
Azacitidine—DNMT3A—Dexamethasone—Methylprednisolone—psoriatic arthritis	0.00153	0.0259	CbGdCrCtD
Azacitidine—DNMT3A—Betamethasone—Methylprednisolone—psoriatic arthritis	0.00153	0.0259	CbGdCrCtD
Azacitidine—DNMT3A—Betamethasone—Dexamethasone—psoriatic arthritis	0.0015	0.0255	CbGdCrCtD
Azacitidine—DNMT3A—Dexamethasone—Betamethasone—psoriatic arthritis	0.0015	0.0255	CbGdCrCtD
Azacitidine—DNMT3A—Betamethasone—Triamcinolone—psoriatic arthritis	0.00147	0.0249	CbGdCrCtD
Azacitidine—DNMT3A—Dexamethasone—Triamcinolone—psoriatic arthritis	0.00147	0.0249	CbGdCrCtD
Azacitidine—Angiopathy—Prednisone—psoriatic arthritis	0.00144	0.00155	CcSEcCtD
Azacitidine—Confusional state—Methylprednisolone—psoriatic arthritis	0.00143	0.00155	CcSEcCtD
Azacitidine—Immune system disorder—Prednisone—psoriatic arthritis	0.00143	0.00154	CcSEcCtD
Azacitidine—Malaise—Betamethasone—psoriatic arthritis	0.00143	0.00154	CcSEcCtD
Azacitidine—Malaise—Dexamethasone—psoriatic arthritis	0.00143	0.00154	CcSEcCtD
Azacitidine—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00142	0.00154	CcSEcCtD
Azacitidine—Oedema—Triamcinolone—psoriatic arthritis	0.00142	0.00154	CcSEcCtD
Azacitidine—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00142	0.00153	CcSEcCtD
Azacitidine—Syncope—Dexamethasone—psoriatic arthritis	0.00142	0.00153	CcSEcCtD
Azacitidine—Syncope—Betamethasone—psoriatic arthritis	0.00142	0.00153	CcSEcCtD
Azacitidine—Infection—Triamcinolone—psoriatic arthritis	0.00142	0.00153	CcSEcCtD
Azacitidine—Infection—Methylprednisolone—psoriatic arthritis	0.00141	0.00152	CcSEcCtD
Azacitidine—Haematuria—Methotrexate—psoriatic arthritis	0.00141	0.00152	CcSEcCtD
Azacitidine—Shock—Triamcinolone—psoriatic arthritis	0.0014	0.00151	CcSEcCtD
Azacitidine—Insomnia—Prednisolone—psoriatic arthritis	0.0014	0.00151	CcSEcCtD
Azacitidine—Alopecia—Prednisone—psoriatic arthritis	0.0014	0.00151	CcSEcCtD
Azacitidine—Shock—Methylprednisolone—psoriatic arthritis	0.0014	0.00151	CcSEcCtD
Azacitidine—DNMT3A—Dexamethasone—Prednisone—psoriatic arthritis	0.0014	0.0236	CbGdCrCtD
Azacitidine—DNMT3A—Betamethasone—Prednisone—psoriatic arthritis	0.0014	0.0236	CbGdCrCtD
Azacitidine—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.0014	0.0015	CcSEcCtD
Azacitidine—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00139	0.0015	CcSEcCtD
Azacitidine—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00139	0.0015	CcSEcCtD
Azacitidine—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00139	0.0015	CcSEcCtD
Azacitidine—Epistaxis—Methotrexate—psoriatic arthritis	0.00139	0.0015	CcSEcCtD
Azacitidine—Tachycardia—Triamcinolone—psoriatic arthritis	0.00139	0.0015	CcSEcCtD
Azacitidine—Mental disorder—Prednisone—psoriatic arthritis	0.00139	0.0015	CcSEcCtD
Azacitidine—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00139	0.0015	CcSEcCtD
Azacitidine—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00138	0.00149	CcSEcCtD
Azacitidine—Erythema—Prednisone—psoriatic arthritis	0.00138	0.00149	CcSEcCtD
Azacitidine—Malnutrition—Prednisone—psoriatic arthritis	0.00138	0.00149	CcSEcCtD
Azacitidine—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00138	0.00149	CcSEcCtD
Azacitidine—Agranulocytosis—Methotrexate—psoriatic arthritis	0.00138	0.00148	CcSEcCtD
Azacitidine—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00137	0.00148	CcSEcCtD
Azacitidine—Convulsion—Dexamethasone—psoriatic arthritis	0.00137	0.00148	CcSEcCtD
Azacitidine—Convulsion—Betamethasone—psoriatic arthritis	0.00137	0.00148	CcSEcCtD
Azacitidine—Hypertension—Betamethasone—psoriatic arthritis	0.00137	0.00148	CcSEcCtD
Azacitidine—Hypertension—Dexamethasone—psoriatic arthritis	0.00137	0.00148	CcSEcCtD
Azacitidine—DNMT3A—Betamethasone—Prednisolone—psoriatic arthritis	0.00136	0.0231	CbGdCrCtD
Azacitidine—DNMT3A—Dexamethasone—Prednisolone—psoriatic arthritis	0.00136	0.0231	CbGdCrCtD
Azacitidine—Myalgia—Dexamethasone—psoriatic arthritis	0.00135	0.00145	CcSEcCtD
Azacitidine—Myalgia—Betamethasone—psoriatic arthritis	0.00135	0.00145	CcSEcCtD
Azacitidine—Anxiety—Betamethasone—psoriatic arthritis	0.00134	0.00145	CcSEcCtD
Azacitidine—Anxiety—Dexamethasone—psoriatic arthritis	0.00134	0.00145	CcSEcCtD
Azacitidine—Discomfort—Betamethasone—psoriatic arthritis	0.00133	0.00144	CcSEcCtD
Azacitidine—Discomfort—Dexamethasone—psoriatic arthritis	0.00133	0.00144	CcSEcCtD
Azacitidine—Haemoglobin—Methotrexate—psoriatic arthritis	0.00133	0.00144	CcSEcCtD
Azacitidine—Hypotension—Methylprednisolone—psoriatic arthritis	0.00133	0.00143	CcSEcCtD
Azacitidine—Pain—Prednisolone—psoriatic arthritis	0.00132	0.00143	CcSEcCtD
Azacitidine—Haemorrhage—Methotrexate—psoriatic arthritis	0.00132	0.00143	CcSEcCtD
Azacitidine—Pharyngitis—Methotrexate—psoriatic arthritis	0.00131	0.00142	CcSEcCtD
Azacitidine—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.00131	0.00141	CcSEcCtD
Azacitidine—Urethral disorder—Methotrexate—psoriatic arthritis	0.0013	0.0014	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.0013	0.0014	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.0013	0.0014	CcSEcCtD
Azacitidine—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00129	0.00139	CcSEcCtD
Azacitidine—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00129	0.00139	CcSEcCtD
Azacitidine—Oedema—Dexamethasone—psoriatic arthritis	0.00129	0.00139	CcSEcCtD
Azacitidine—Oedema—Betamethasone—psoriatic arthritis	0.00129	0.00139	CcSEcCtD
Azacitidine—Insomnia—Triamcinolone—psoriatic arthritis	0.00129	0.00139	CcSEcCtD
Azacitidine—Insomnia—Methylprednisolone—psoriatic arthritis	0.00129	0.00139	CcSEcCtD
Azacitidine—Infection—Dexamethasone—psoriatic arthritis	0.00128	0.00139	CcSEcCtD
Azacitidine—Infection—Betamethasone—psoriatic arthritis	0.00128	0.00139	CcSEcCtD
Azacitidine—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00128	0.00138	CcSEcCtD
Azacitidine—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00128	0.00138	CcSEcCtD
Azacitidine—Anaemia—Prednisone—psoriatic arthritis	0.00128	0.00138	CcSEcCtD
Azacitidine—Shock—Betamethasone—psoriatic arthritis	0.00127	0.00137	CcSEcCtD
Azacitidine—Shock—Dexamethasone—psoriatic arthritis	0.00127	0.00137	CcSEcCtD
Azacitidine—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00127	0.00137	CcSEcCtD
Azacitidine—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00127	0.00137	CcSEcCtD
Azacitidine—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00127	0.00137	CcSEcCtD
Azacitidine—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00127	0.00137	CcSEcCtD
Azacitidine—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00127	0.00137	CcSEcCtD
Azacitidine—Tachycardia—Betamethasone—psoriatic arthritis	0.00126	0.00136	CcSEcCtD
Azacitidine—Tachycardia—Dexamethasone—psoriatic arthritis	0.00126	0.00136	CcSEcCtD
Azacitidine—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00125	0.00135	CcSEcCtD
Azacitidine—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00125	0.00135	CcSEcCtD
Azacitidine—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00125	0.00135	CcSEcCtD
Azacitidine—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00125	0.00135	CcSEcCtD
Azacitidine—Malaise—Prednisone—psoriatic arthritis	0.00124	0.00134	CcSEcCtD
Azacitidine—Eye disorder—Methotrexate—psoriatic arthritis	0.00124	0.00133	CcSEcCtD
Azacitidine—Syncope—Prednisone—psoriatic arthritis	0.00124	0.00133	CcSEcCtD
Azacitidine—Anorexia—Dexamethasone—psoriatic arthritis	0.00123	0.00133	CcSEcCtD
Azacitidine—Anorexia—Betamethasone—psoriatic arthritis	0.00123	0.00133	CcSEcCtD
Azacitidine—Urticaria—Prednisolone—psoriatic arthritis	0.00123	0.00133	CcSEcCtD
Azacitidine—Cardiac disorder—Methotrexate—psoriatic arthritis	0.00123	0.00133	CcSEcCtD
Azacitidine—Fatigue—Triamcinolone—psoriatic arthritis	0.00123	0.00132	CcSEcCtD
Azacitidine—Fatigue—Methylprednisolone—psoriatic arthritis	0.00123	0.00132	CcSEcCtD
Azacitidine—Pain—Triamcinolone—psoriatic arthritis	0.00122	0.00131	CcSEcCtD
Azacitidine—Loss of consciousness—Prednisone—psoriatic arthritis	0.00121	0.00131	CcSEcCtD
Azacitidine—Hypotension—Dexamethasone—psoriatic arthritis	0.00121	0.0013	CcSEcCtD
Azacitidine—Hypotension—Betamethasone—psoriatic arthritis	0.00121	0.0013	CcSEcCtD
Azacitidine—Angiopathy—Methotrexate—psoriatic arthritis	0.0012	0.0013	CcSEcCtD
Azacitidine—Immune system disorder—Methotrexate—psoriatic arthritis	0.0012	0.00129	CcSEcCtD
Azacitidine—Convulsion—Prednisone—psoriatic arthritis	0.0012	0.00129	CcSEcCtD
Azacitidine—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00119	0.00129	CcSEcCtD
Azacitidine—Hypertension—Prednisone—psoriatic arthritis	0.00119	0.00128	CcSEcCtD
Azacitidine—Chills—Methotrexate—psoriatic arthritis	0.00119	0.00128	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00118	0.00127	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00118	0.00127	CcSEcCtD
Azacitidine—Myalgia—Prednisone—psoriatic arthritis	0.00117	0.00127	CcSEcCtD
Azacitidine—Arthralgia—Prednisone—psoriatic arthritis	0.00117	0.00127	CcSEcCtD
Azacitidine—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00117	0.00127	CcSEcCtD
Azacitidine—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00117	0.00126	CcSEcCtD
Azacitidine—Anxiety—Prednisone—psoriatic arthritis	0.00117	0.00126	CcSEcCtD
Azacitidine—Alopecia—Methotrexate—psoriatic arthritis	0.00117	0.00126	CcSEcCtD
Azacitidine—Insomnia—Dexamethasone—psoriatic arthritis	0.00117	0.00126	CcSEcCtD
Azacitidine—Insomnia—Betamethasone—psoriatic arthritis	0.00117	0.00126	CcSEcCtD
Azacitidine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00117	0.00126	CcSEcCtD
Azacitidine—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00116	0.00125	CcSEcCtD
Azacitidine—Discomfort—Prednisone—psoriatic arthritis	0.00116	0.00125	CcSEcCtD
Azacitidine—Mental disorder—Methotrexate—psoriatic arthritis	0.00116	0.00125	CcSEcCtD
Azacitidine—DNMT1—Betamethasone—Methylprednisolone—psoriatic arthritis	0.00116	0.0196	CbGdCrCtD
Azacitidine—DNMT1—Dexamethasone—Methylprednisolone—psoriatic arthritis	0.00116	0.0196	CbGdCrCtD
Azacitidine—Erythema—Methotrexate—psoriatic arthritis	0.00115	0.00124	CcSEcCtD
Azacitidine—Malnutrition—Methotrexate—psoriatic arthritis	0.00115	0.00124	CcSEcCtD
Azacitidine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00114	0.00123	CcSEcCtD
Azacitidine—DNMT1—Betamethasone—Dexamethasone—psoriatic arthritis	0.00114	0.0193	CbGdCrCtD
Azacitidine—DNMT1—Dexamethasone—Betamethasone—psoriatic arthritis	0.00114	0.0193	CbGdCrCtD
Azacitidine—Dyspepsia—Betamethasone—psoriatic arthritis	0.00114	0.00123	CcSEcCtD
Azacitidine—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00114	0.00123	CcSEcCtD
Azacitidine—Urticaria—Triamcinolone—psoriatic arthritis	0.00113	0.00122	CcSEcCtD
Azacitidine—Urticaria—Methylprednisolone—psoriatic arthritis	0.00113	0.00122	CcSEcCtD
Azacitidine—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00113	0.00121	CcSEcCtD
Azacitidine—Anaphylactic shock—Prednisone—psoriatic arthritis	0.00113	0.00121	CcSEcCtD
Azacitidine—Oedema—Prednisone—psoriatic arthritis	0.00113	0.00121	CcSEcCtD
Azacitidine—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00112	0.00121	CcSEcCtD
Azacitidine—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00112	0.00121	CcSEcCtD
Azacitidine—Decreased appetite—Betamethasone—psoriatic arthritis	0.00112	0.00121	CcSEcCtD
Azacitidine—Infection—Prednisone—psoriatic arthritis	0.00112	0.00121	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00112	0.0012	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00112	0.0012	CcSEcCtD
Azacitidine—Back pain—Methotrexate—psoriatic arthritis	0.00112	0.0012	CcSEcCtD
Azacitidine—Fatigue—Betamethasone—psoriatic arthritis	0.00111	0.0012	CcSEcCtD
Azacitidine—Fatigue—Dexamethasone—psoriatic arthritis	0.00111	0.0012	CcSEcCtD
Azacitidine—DNMT1—Betamethasone—Triamcinolone—psoriatic arthritis	0.00111	0.0189	CbGdCrCtD
Azacitidine—DNMT1—Dexamethasone—Triamcinolone—psoriatic arthritis	0.00111	0.0189	CbGdCrCtD
Azacitidine—Shock—Prednisone—psoriatic arthritis	0.00111	0.00119	CcSEcCtD
Azacitidine—Pain—Dexamethasone—psoriatic arthritis	0.00111	0.00119	CcSEcCtD
Azacitidine—Pain—Betamethasone—psoriatic arthritis	0.00111	0.00119	CcSEcCtD
Azacitidine—Nervous system disorder—Prednisone—psoriatic arthritis	0.0011	0.00119	CcSEcCtD
Azacitidine—Tachycardia—Prednisone—psoriatic arthritis	0.0011	0.00119	CcSEcCtD
Azacitidine—Skin disorder—Prednisone—psoriatic arthritis	0.00109	0.00118	CcSEcCtD
Azacitidine—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00109	0.00117	CcSEcCtD
Azacitidine—Anorexia—Prednisone—psoriatic arthritis	0.00107	0.00116	CcSEcCtD
Azacitidine—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.00107	0.00115	CcSEcCtD
Azacitidine—Anaemia—Methotrexate—psoriatic arthritis	0.00107	0.00115	CcSEcCtD
Azacitidine—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00107	0.00115	CcSEcCtD
Azacitidine—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00107	0.00115	CcSEcCtD
Azacitidine—DNMT1—Betamethasone—Prednisone—psoriatic arthritis	0.00106	0.0179	CbGdCrCtD
Azacitidine—DNMT1—Dexamethasone—Prednisone—psoriatic arthritis	0.00106	0.0179	CbGdCrCtD
Azacitidine—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00106	0.00114	CcSEcCtD
Azacitidine—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00106	0.00114	CcSEcCtD
Azacitidine—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00105	0.00113	CcSEcCtD
Azacitidine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00105	0.00113	CcSEcCtD
Azacitidine—Malaise—Methotrexate—psoriatic arthritis	0.00104	0.00112	CcSEcCtD
Azacitidine—DNMT1—Dexamethasone—Prednisolone—psoriatic arthritis	0.00103	0.0175	CbGdCrCtD
Azacitidine—DNMT1—Betamethasone—Prednisolone—psoriatic arthritis	0.00103	0.0175	CbGdCrCtD
Azacitidine—Leukopenia—Methotrexate—psoriatic arthritis	0.00103	0.00111	CcSEcCtD
Azacitidine—Urticaria—Betamethasone—psoriatic arthritis	0.00103	0.00111	CcSEcCtD
Azacitidine—Urticaria—Dexamethasone—psoriatic arthritis	0.00103	0.00111	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.00103	0.00111	CcSEcCtD
Azacitidine—Dizziness—Prednisolone—psoriatic arthritis	0.00102	0.00111	CcSEcCtD
Azacitidine—Asthenia—Triamcinolone—psoriatic arthritis	0.00102	0.0011	CcSEcCtD
Azacitidine—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00102	0.0011	CcSEcCtD
Azacitidine—Abdominal pain—Betamethasone—psoriatic arthritis	0.00102	0.0011	CcSEcCtD
Azacitidine—Body temperature increased—Betamethasone—psoriatic arthritis	0.00102	0.0011	CcSEcCtD
Azacitidine—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00102	0.0011	CcSEcCtD
Azacitidine—Asthenia—Methylprednisolone—psoriatic arthritis	0.00102	0.0011	CcSEcCtD
Azacitidine—Insomnia—Prednisone—psoriatic arthritis	0.00102	0.0011	CcSEcCtD
Azacitidine—Pruritus—Triamcinolone—psoriatic arthritis	0.00101	0.00109	CcSEcCtD
Azacitidine—Cough—Methotrexate—psoriatic arthritis	0.00101	0.00109	CcSEcCtD
Azacitidine—Pruritus—Methylprednisolone—psoriatic arthritis	0.00101	0.00108	CcSEcCtD
Azacitidine—Convulsion—Methotrexate—psoriatic arthritis	0.000999	0.00108	CcSEcCtD
Azacitidine—Dyspepsia—Prednisone—psoriatic arthritis	0.000991	0.00107	CcSEcCtD
Azacitidine—Chest pain—Methotrexate—psoriatic arthritis	0.000982	0.00106	CcSEcCtD
Azacitidine—Arthralgia—Methotrexate—psoriatic arthritis	0.000982	0.00106	CcSEcCtD
Azacitidine—Myalgia—Methotrexate—psoriatic arthritis	0.000982	0.00106	CcSEcCtD
Azacitidine—Decreased appetite—Prednisone—psoriatic arthritis	0.000979	0.00106	CcSEcCtD
Azacitidine—Rash—Prednisolone—psoriatic arthritis	0.000977	0.00105	CcSEcCtD
Azacitidine—Dermatitis—Prednisolone—psoriatic arthritis	0.000976	0.00105	CcSEcCtD
Azacitidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000975	0.00105	CcSEcCtD
Azacitidine—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000973	0.00105	CcSEcCtD
Azacitidine—Fatigue—Prednisone—psoriatic arthritis	0.000971	0.00105	CcSEcCtD
Azacitidine—Headache—Prednisolone—psoriatic arthritis	0.000971	0.00105	CcSEcCtD
Azacitidine—Discomfort—Methotrexate—psoriatic arthritis	0.00097	0.00105	CcSEcCtD
Azacitidine—Constipation—Prednisone—psoriatic arthritis	0.000963	0.00104	CcSEcCtD
Azacitidine—Confusional state—Methotrexate—psoriatic arthritis	0.000949	0.00102	CcSEcCtD
Azacitidine—Dizziness—Triamcinolone—psoriatic arthritis	0.000942	0.00102	CcSEcCtD
Azacitidine—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000941	0.00101	CcSEcCtD
Azacitidine—Dizziness—Methylprednisolone—psoriatic arthritis	0.00094	0.00101	CcSEcCtD
Azacitidine—Infection—Methotrexate—psoriatic arthritis	0.000935	0.00101	CcSEcCtD
Azacitidine—Feeling abnormal—Prednisone—psoriatic arthritis	0.000928	0.001	CcSEcCtD
Azacitidine—Asthenia—Dexamethasone—psoriatic arthritis	0.000928	0.001	CcSEcCtD
Azacitidine—Asthenia—Betamethasone—psoriatic arthritis	0.000928	0.001	CcSEcCtD
Azacitidine—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000923	0.000995	CcSEcCtD
Azacitidine—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000921	0.000994	CcSEcCtD
Azacitidine—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000921	0.000993	CcSEcCtD
Azacitidine—Nausea—Prednisolone—psoriatic arthritis	0.00092	0.000993	CcSEcCtD
Azacitidine—Pruritus—Betamethasone—psoriatic arthritis	0.000915	0.000987	CcSEcCtD
Azacitidine—Pruritus—Dexamethasone—psoriatic arthritis	0.000915	0.000987	CcSEcCtD
Azacitidine—Skin disorder—Methotrexate—psoriatic arthritis	0.000914	0.000986	CcSEcCtD
Azacitidine—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00091	0.000981	CcSEcCtD
Azacitidine—Vomiting—Triamcinolone—psoriatic arthritis	0.000906	0.000977	CcSEcCtD
Azacitidine—Vomiting—Methylprednisolone—psoriatic arthritis	0.000904	0.000975	CcSEcCtD
Azacitidine—Rash—Triamcinolone—psoriatic arthritis	0.000898	0.000969	CcSEcCtD
Azacitidine—Dermatitis—Triamcinolone—psoriatic arthritis	0.000898	0.000968	CcSEcCtD
Azacitidine—Anorexia—Methotrexate—psoriatic arthritis	0.000897	0.000967	CcSEcCtD
Azacitidine—Rash—Methylprednisolone—psoriatic arthritis	0.000896	0.000967	CcSEcCtD
Azacitidine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000896	0.000966	CcSEcCtD
Azacitidine—Urticaria—Prednisone—psoriatic arthritis	0.000894	0.000965	CcSEcCtD
Azacitidine—Headache—Triamcinolone—psoriatic arthritis	0.000893	0.000963	CcSEcCtD
Azacitidine—Headache—Methylprednisolone—psoriatic arthritis	0.000891	0.000961	CcSEcCtD
Azacitidine—Body temperature increased—Prednisone—psoriatic arthritis	0.00089	0.00096	CcSEcCtD
Azacitidine—Abdominal pain—Prednisone—psoriatic arthritis	0.00089	0.00096	CcSEcCtD
Azacitidine—Diarrhoea—Betamethasone—psoriatic arthritis	0.000885	0.000954	CcSEcCtD
Azacitidine—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000885	0.000954	CcSEcCtD
Azacitidine—Hypotension—Methotrexate—psoriatic arthritis	0.000879	0.000948	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000857	0.000925	CcSEcCtD
Azacitidine—Dizziness—Dexamethasone—psoriatic arthritis	0.000855	0.000922	CcSEcCtD
Azacitidine—Dizziness—Betamethasone—psoriatic arthritis	0.000855	0.000922	CcSEcCtD
Azacitidine—Insomnia—Methotrexate—psoriatic arthritis	0.000851	0.000918	CcSEcCtD
Azacitidine—Nausea—Triamcinolone—psoriatic arthritis	0.000846	0.000913	CcSEcCtD
Azacitidine—Nausea—Methylprednisolone—psoriatic arthritis	0.000844	0.000911	CcSEcCtD
Azacitidine—Dyspnoea—Methotrexate—psoriatic arthritis	0.000839	0.000905	CcSEcCtD
Azacitidine—Hypersensitivity—Prednisone—psoriatic arthritis	0.000829	0.000895	CcSEcCtD
Azacitidine—Dyspepsia—Methotrexate—psoriatic arthritis	0.000828	0.000893	CcSEcCtD
Azacitidine—Vomiting—Betamethasone—psoriatic arthritis	0.000822	0.000887	CcSEcCtD
Azacitidine—Vomiting—Dexamethasone—psoriatic arthritis	0.000822	0.000887	CcSEcCtD
Azacitidine—Decreased appetite—Methotrexate—psoriatic arthritis	0.000818	0.000882	CcSEcCtD
Azacitidine—Rash—Dexamethasone—psoriatic arthritis	0.000815	0.000879	CcSEcCtD
Azacitidine—Rash—Betamethasone—psoriatic arthritis	0.000815	0.000879	CcSEcCtD
Azacitidine—Dermatitis—Betamethasone—psoriatic arthritis	0.000814	0.000878	CcSEcCtD
Azacitidine—Dermatitis—Dexamethasone—psoriatic arthritis	0.000814	0.000878	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000812	0.000876	CcSEcCtD
Azacitidine—Fatigue—Methotrexate—psoriatic arthritis	0.000811	0.000875	CcSEcCtD
Azacitidine—Headache—Dexamethasone—psoriatic arthritis	0.00081	0.000874	CcSEcCtD
Azacitidine—Headache—Betamethasone—psoriatic arthritis	0.00081	0.000874	CcSEcCtD
Azacitidine—Asthenia—Prednisone—psoriatic arthritis	0.000808	0.000871	CcSEcCtD
Azacitidine—Pain—Methotrexate—psoriatic arthritis	0.000805	0.000868	CcSEcCtD
Azacitidine—Pruritus—Prednisone—psoriatic arthritis	0.000797	0.000859	CcSEcCtD
Azacitidine—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000775	0.000836	CcSEcCtD
Azacitidine—Diarrhoea—Prednisone—psoriatic arthritis	0.00077	0.000831	CcSEcCtD
Azacitidine—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000769	0.00083	CcSEcCtD
Azacitidine—Nausea—Dexamethasone—psoriatic arthritis	0.000768	0.000828	CcSEcCtD
Azacitidine—Nausea—Betamethasone—psoriatic arthritis	0.000768	0.000828	CcSEcCtD
Azacitidine—Urticaria—Methotrexate—psoriatic arthritis	0.000747	0.000806	CcSEcCtD
Azacitidine—Dizziness—Prednisone—psoriatic arthritis	0.000744	0.000803	CcSEcCtD
Azacitidine—Abdominal pain—Methotrexate—psoriatic arthritis	0.000744	0.000802	CcSEcCtD
Azacitidine—Body temperature increased—Methotrexate—psoriatic arthritis	0.000744	0.000802	CcSEcCtD
Azacitidine—Vomiting—Prednisone—psoriatic arthritis	0.000716	0.000772	CcSEcCtD
Azacitidine—Rash—Prednisone—psoriatic arthritis	0.00071	0.000766	CcSEcCtD
Azacitidine—Dermatitis—Prednisone—psoriatic arthritis	0.000709	0.000765	CcSEcCtD
Azacitidine—Headache—Prednisone—psoriatic arthritis	0.000705	0.000761	CcSEcCtD
Azacitidine—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000693	0.000748	CcSEcCtD
Azacitidine—Asthenia—Methotrexate—psoriatic arthritis	0.000675	0.000728	CcSEcCtD
Azacitidine—Nausea—Prednisone—psoriatic arthritis	0.000669	0.000721	CcSEcCtD
Azacitidine—Pruritus—Methotrexate—psoriatic arthritis	0.000666	0.000718	CcSEcCtD
Azacitidine—Diarrhoea—Methotrexate—psoriatic arthritis	0.000644	0.000694	CcSEcCtD
Azacitidine—Dizziness—Methotrexate—psoriatic arthritis	0.000622	0.000671	CcSEcCtD
Azacitidine—Vomiting—Methotrexate—psoriatic arthritis	0.000598	0.000645	CcSEcCtD
Azacitidine—Rash—Methotrexate—psoriatic arthritis	0.000593	0.00064	CcSEcCtD
Azacitidine—Dermatitis—Methotrexate—psoriatic arthritis	0.000593	0.000639	CcSEcCtD
Azacitidine—Headache—Methotrexate—psoriatic arthritis	0.000589	0.000636	CcSEcCtD
Azacitidine—Nausea—Methotrexate—psoriatic arthritis	0.000559	0.000603	CcSEcCtD
